Public Company News

Caravelle Reports Half Year 2023 Financial Results

SINGAPORE, Feb. 29, 2024 /PRNewswire/ -- Caravelle International Group (the "Company", Nasdaq: CACO), a trailblazing global ocean technology company, today announced its unaudited and unreviewed financial results for the six months endedApril 30, 2023. Half year 2023 Financial Highlights Six...

2024-02-29 22:00 4565

Golden Heaven Group Holdings Ltd. to Expand into Indonesia Market with its Strategic Partnership

NANPING, China, Feb. 29, 2024 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (the "Company" or "Golden Heaven") (Nasdaq: GDHG), an amusement park operator in China, announced today that on February 26, 2024, it entered into a Letter of Intent for Strategic Partnership ("LOI") with PT BESTAR JAY...

2024-02-29 21:00 3765

Canadian Solar Celebrates Contribution to Historic 100% Renewable Energy-Powered Super Bowl LVIII in Las Vegas

GUELPH, ON, Feb. 29, 2024 /PRNewswire/ -- Canadian Solar Inc.  (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) announced today its pivotal role in powering the Super Bowl LVIIIthat was held at Allegiant Stadium in Las Vegas, Nevada on February 11, 2024. The firs...

2024-02-29 20:00 3700

MINISO Group Will Report December Quarter 2023 Financial Results on March 12, 2024

GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design,today announced that it plans to release its December quar...

2024-02-29 17:48 4079

Dingdong (Cayman) Limited Announces Fourth Quarter 2023 Financial Results

SHANGHAI, Feb. 29, 2024 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced its unaudited financial results for the quarter endedDecember 31, 2023. Fourth...

2024-02-29 17:36 3793

Youdao Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

HANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2023. Fourth Qua...

2024-02-29 16:30 3683

NetEase Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

HANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2023. Fourth Quarter 202...

2024-02-29 16:30 4494

Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method

A World Health Organization report highlights that a third of the global adult population suffers from hypertension, with nearly half undiagnosed due to inadequate blood pressure meters, posing significant health risks. BEIJING, Feb. 28, 2024 /PRNewswire/ -- Hanvon Technology Co., Ltd., based in ...

2024-02-29 15:13 2446

"Bleach: Brave Souls" Reaches Over 85 Million Downloads Worldwide Giving Users the Chance to Receive a 6 Star Summons Ticket in an Awesome Campaign

TOKYO, Feb. 29, 2024 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its hit 3D action gameBleach: Brave Souls, currently available on smartphones, PC, and PlayStation 4, has reached a total of 85 million downloads worldwide. See theoriginal press release

2024-02-29 15:10 2549

Gauss Labs and SK hynix Publish the Latest Results on AI-based Semiconductor Metrology Technology at SPIE AL 2024

-  Two joint academic papers on AI-based metrology technology presented -  Gauss Labs's innovative technology improves process control and equipment productivity in semiconductor manufacturing -  Gauss Labs is at the forefront, leading industrial AI efforts to transform the manufacturing industr...

2024-02-29 13:50 2907

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results

BEIJING, Feb. 29, 2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2023. Fourth Quarte...

2024-02-29 13:01 3657

MiTAC Unleashes Revolutionary Server Solutions, Powering Ahead with 5th Gen Intel® Xeon® Scalable Processors Accelerated by Intel Data Center GPUs

NEWARK, Calif., Feb. 28, 2024 /PRNewswire/ -- MiTAC Computing Technology, a subsidiary of MiTAC Holdings Corp. (TSE:3706), proudly reveals its groundbreaking suite of server solutions that deliver unsurpassed capabilities with the5th Gen Intel® Xeon® Scalable Processors

2024-02-29 01:00 2489

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammography double-reading settings  SEOUL, South Korea, Feb. 28...

2024-02-28 22:03 2501

CLPS Incorporation to Announce First Half of Fiscal 2024 Financial Results

HONG KONG, Feb. 28, 2024 /PRNewswire/ -- CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or the "Company"), today announced that it will release its financial results for the six months endedDecember 31, 2023, or the first half of the Company's fiscal year 2024, before the market opens onTuesday, March...

2024-02-28 21:30 2285

PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS

Highlights: * Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® * Preliminary efficacy data shows a 58% reduction in the rate of disease progression for Cohort 2 (High Dose) using the FDA primary efficacy endpoint, ALSFRS-R * Confirmation that m...

2024-02-28 20:47 2365

Daqo New Energy Announces Unaudited Fourth Quarter and Fiscal Year 2023 Results

SHANGHAI, Feb. 28, 2024 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced its unaudited financial results for the fourth quarter and fiscal year of 2023. ...

2024-02-28 19:00 4096

Vipshop Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 28, 2024 GUANGZHOU, China, Feb. 28, 2024 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), today announced its unaudited financial results...

2024-02-28 18:00 4204

JinkoSolar Becomes Premium Sponsor of the Team Gresini Racing for MotoE World Championship 2024

PADOVA, Italy, Feb. 28, 2024 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced its premium sponsorship collaboration with Gresini Racing S.r.l.("Gresini Racing")...

2024-02-28 18:00 2343

Yatsen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024

GUANGZHOU, China, Feb. 28, 2024 /PRNewswire/ – Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leadingChina-based beauty group, today announced that it will release its unaudited financial results for the fourth quarter and full year endedDecember 31, 2023, on Wednesday, March 6...

2024-02-28 18:00 2297

The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Cancer Research

HONG KONG, Feb. 28, 2024 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody(cadonilimab)combined with standard treatment (chemotherapy +/- bevacizumab) as first-line treatment for recurrent/metastatic cervical cancer had be...

2024-02-28 17:27 2721
1 ... 334335336337338339340 ... 765

Week's Top Stories